Exelixis Inc
(NAS:EXEL)
$
35.92
0.07 (0.2%)
Market Cap: 10.26 Bil
Enterprise Value: 9.21 Bil
PE Ratio: 23.03
PB Ratio: 4.51
GF Score: 91/100 
Exelixis Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022 / 08:05PM GMT
Release Date Price:
$17.14
(-4.62%)
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and welcome to the Morgan Stanley Global Healthcare Conference. I'm Jeff Hung, one of the biotech analysts. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
For this session, we have Exelixis with CEO, Mike Morrissey. Welcome, Mike.
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
Jeff, good to see you.
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
Good to see you. So for those who may not be familiar with Exelixis, can you provide a brief introduction?
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
For sure. So before I begin, I'll just remind you that we'll be making
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers